Plain-English translation of NCT07099430 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called LBL-024 for people with advanced melanoma (a serious form of skin cancer). Researchers want to see if this treatment works better when used alone or when combined with other medications. The study has two main phases: first, they'll test safety and effectiveness in smaller groups, then expand to larger groups to confirm the best approach.
Melanoma is a dangerous cancer that can spread throughout the body, and current treatments don't work for everyone. This trial exists to see if this new medication or its combinations could offer better outcomes and give patients more treatment options.
You likely qualify if…
You likely don't qualify if…
You will receive intravenous infusions (IV medications through your veins) of the treatment medication on a regular schedule. Depending on which treatment group you're in, you might receive one medication or a combination of two. You'll have regular clinic visits for blood tests, imaging scans, and check-ins with your doctor to monitor how well the treatment is working and watch for any side effects. The study has two phases, starting with smaller groups to check safety, then expanding to larger groups to confirm effectiveness.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China